ARTICLE | Financial News
Gradalis raises $24M in series B
January 4, 2013 12:51 AM UTC
Gradalis Inc. (Carrollton, Texas) raised $24 million in a series B round from undisclosed investors. The company's FANG vaccine is in Phase II testing to treat patients with advanced ovarian cancer, a...